The Irbesartan type II diabetic nephropathy trial: study design and baseline patient characteristics. For the Collaborative Study Group

The Irbesartan type II diabetic nephropathy trial: study design and baseline patient characteristics. For the Collaborative Study Group

Item
http://www.wikidata.org/entity/Q28373805
Protection against death and renal failure by renin-angiotensin system blockers in patients with diabetes and kidney disease.Hypertensive therapy: attacking the renin-angiotensin systemBilirubin: a potential biomarker and therapeutic target for diabetic nephropathy.RAS blockade: new possibilities in the treatment of complications of diabetes.Early chronic kidney disease: diagnosis, management and models of careAngiotensin receptor blockers for the reduction of proteinuria in diabetic patients with overt nephropathy: results from the AMADEO study.Association of Salivary Osteopontin Levels with Glycaemic Status and Microalbuminuria - in Patients with Type 2 Diabetes Mellitus.Aldosterone blockade in chronic kidney disease: can it improve outcome?Is Chronic Dialysis the Right Hard Renal End Point To Evaluate Renoprotective Drug Effects?Intratubular Renin-Angiotensin System in Hypertension.Methods of Blood Pressure Assessment Used in Milestone Hypertension Trials
P2860

The Irbesartan type II diabetic nephropathy trial: study design and baseline patient characteristics. For the Collaborative Study Group

Item
http://www.wikidata.org/entity/Q28373805
description
2000 nî lūn-bûn
@nan
2000 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
The Irbesartan type II diabeti ...... the Collaborative Study Group
@ast
The Irbesartan type II diabeti ...... the Collaborative Study Group
@en
The Irbesartan type II diabeti ...... the Collaborative Study Group
@nl
type
label
The Irbesartan type II diabeti ...... the Collaborative Study Group
@ast
The Irbesartan type II diabeti ...... the Collaborative Study Group
@en
The Irbesartan type II diabeti ...... the Collaborative Study Group
@nl
prefLabel
The Irbesartan type II diabeti ...... the Collaborative Study Group
@ast
The Irbesartan type II diabeti ...... the Collaborative Study Group
@en
The Irbesartan type II diabeti ...... the Collaborative Study Group
@nl
P1433
P1476
P2093
P304
P31
P407
P433
P478
P577
P698
P921
P1433
P1476
The Irbesartan type II diabeti ...... the Collaborative Study Group
@en
P2093
P304
P31
P407
P433
P478
P577
P698
P921